Global Prospective, Observational Cohort of Adult Patients With Primary Sclerosing Cholangitis (WIND-PSC Study)
NCT06297993 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 2000
Last updated 2026-05-08
Summary
Develop an appropriate real-world data comparator cohort to support the design, execution, and serve as an external control for interventional clinical trials in PSC.
Conditions
- PSC
Sponsors & Collaborators
-
PSC Partners Seeking a Cure
lead OTHER
Principal Investigators
-
Cynthia Levy, MD · University of Miami
-
Stephen Rossi, PharmD · PSC Partners Seeking a Cure
Eligibility
- Min Age
- 18 Years
- Max Age
- 75 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2024-05-06
- Primary Completion
- 2029-01-31
- Completion
- 2031-01-31
Countries
- United States
- Canada
- Germany
- Italy
- New Zealand
- United Kingdom
Study Locations
More Related Trials
-
CS0159 in Chinese Patients With PSC (Primary Sclerosing Cholangitis)
NCT05896137 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Trial of High-dose Urso in Primary Sclerosing Cholangitis
NCT00059202 ·Status: TERMINATED ·Phase: PHASE2/PHASE3
-
A Study to Assess the Safety and Efficacy of LB-P8 in Patients With PSC
NCT06699121 ·Status: RECRUITING ·Phase: PHASE2
-
Effect and Safety of Oral Vancomycin in Primary Sclerosing Cholangitis Patients
NCT02605213 ·Status: UNKNOWN ·Phase: PHASE4
-
Colangioids to Define the Genetic Factors Involved in Atypical Primary Sclerosing Cholangitis
NCT06865924 ·Status: RECRUITING ·Phase: NA
-
Mitomycin C Therapy for Patients With Primary Sclerosing Cholangitis
NCT01688024 ·Status: UNKNOWN ·Phase: PHASE2
-
CM-101 in PSC Patients -The SPRING Study
NCT04595825 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Umbilical Cord Mesenchymal Stem Cells in Primary Sclerosing Cholangitis
NCT03516006 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Phase 2a Evaluation of Safety, Tolerability, and Pharmacokinetics of PLN-74809 in Patients With Primary Sclerosing Cholangitis (PSC)
NCT04480840 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of IDN-6556 in Cirrhotic Subjects With Portal Hypertension
NCT02230683 ·Status: COMPLETED ·Phase: PHASE2
-
Safety and Tolerability of Cilofexor in Participants With Primary Sclerosing Cholangitis (PSC) and Compensated Cirrhosis
NCT04060147 ·Status: TERMINATED ·Phase: PHASE1
-
Efficacy and Safety of Pentoxifylline in Improving Oxygenation in Hepatopulmonary Syndrome
NCT05373134 ·Status: UNKNOWN ·Phase: NA
-
Pilot Study of Budesonide for Patients With Primary Sclerosing Cholangitis
NCT00004842 ·Status: COMPLETED ·Phase: PHASE1
-
norUrsodeoxycholic Acid vs Placebo in PSC
NCT03872921 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Pentoxifylline for Primary Biliary Cirrhosis
NCT01249092 ·Status: COMPLETED ·Phase: PHASE2
-
Norursodeoxycholic Acid in the Treatment of Primary Sclerosing Cholangitis
NCT01755507 ·Status: COMPLETED ·Phase: PHASE2
-
A POC and Dose-Ranging Study of HTD1801 in PSC Patients
NCT03333928 ·Status: COMPLETED ·Phase: PHASE2
-
Sulfasalazine for the Treatment of Primary Sclerosing Cholangitis
NCT03561584 ·Status: COMPLETED ·Phase: PHASE2
-
Real-World Data Study to Evaluate the Effectiveness of OCA on Hepatic Outcomes in PBC Patients
NCT05292872 ·Status: COMPLETED
-
A Study to Assess Safety and Effectiveness of Elafibranor in Adult Participants With Primary Sclerosing Cholangitis.
NCT05627362 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
To Study the Safety and Efficacy of Simvastatin in Patients With Hepatopulmonary Syndrome in Cirrhosis.
NCT05187715 ·Status: UNKNOWN ·Phase: NA
-
Effect of Simvastatin on the Prognosis of Primary Primary Sclerosing Cholangitis (PSC)
NCT04133792 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Study to Evaluate the Safety, Tolerability, and Efficacy of Cilofexor in Adults With Primary Sclerosing Cholangitis Without Cirrhosis
NCT02943460 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of IDN-6556 in Subjects With Liver Cirrhosis
NCT02230670 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluation of the Safety and Efficacy of HK-660S in Patients With Primary Sclerosing Cholangitis
NCT05866809 ·Status: COMPLETED ·Phase: PHASE2